Insider Ledger

BCYC insider buying and SEC filings, explained

Bicycle Therapeutics plc · CIK 1761612

Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov

Insider activity in the last 12 months

Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$453K
Planned sales (10b5-1)
$69K

Insider purchases and sales, last 12 months

TradedTypeWhat was filedSource
Oct 2–5, 2026Planned (10b5-1) Amended filingJennifer Scott Perry (President / COO) sold 1,450 shares between Oct 2 and Oct 5 at about $3.54 ($5K), marked as a 10b5-1 plan trade. Holdings down 2% to 89,602 shares. This amends a filing from Oct 6.SEC filing
Filed Oct 7, 2026, 6:24 PM ET
Oct 2, 2026SaleRobert Charles Swanton (Director) sold 3,431 shares at about $3.47 ($12K). Holdings down 18% to 15,782 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Oct 6, 2026, 4:45 PM ET
Oct 2–5, 2026SaleMichael Skynner (Chief Scientific Officer) sold 2,445 shares between Oct 2 and Oct 5 at about $3.49 ($9K). Holdings down 2% to 154,726 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Oct 6, 2026, 4:45 PM ET
Oct 2–5, 2026SaleMichael Charles Ferguson Hannay (Chief Prod & Supply Chain Off) sold 1,814 shares between Oct 2 and Oct 5 at about $3.48 ($6K). Holdings down 2% to 92,561 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Oct 6, 2026, 4:45 PM ET
Oct 2–5, 2026SaleKevin Lee (CEO and Director) sold 7,805 shares between Oct 2 and Oct 5 at about $3.49 ($27K). Holdings down 1% to 595,866 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Oct 6, 2026, 4:45 PM ET
Oct 2–5, 2026SaleTravis Alvin Thompson (CFO) sold 972 shares between Oct 2 and Oct 5 at about $3.48 ($3K). Holdings down 1% to 64,449 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Oct 6, 2026, 4:34 PM ET
Jul 2–6, 2026Planned (10b5-1)Jennifer Scott Perry (President / COO) sold 1,412 shares between Jul 2 and Jul 6 at about $4.29 ($6K), marked as a 10b5-1 plan trade. Holdings down 2% to 91,052 shares.SEC filing
Filed Jul 7, 2026
Jul 2–6, 2026SaleMichael Charles Ferguson Hannay (Chief Prod & Supply Chain Off) sold 1,761 shares between Jul 2 and Jul 6 at about $4.28 ($8K). Holdings down 2% to 94,375 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Jul 7, 2026
Jul 2–6, 2026SaleTravis Alvin Thompson (CFO) sold 923 shares between Jul 2 and Jul 6 at about $4.27 ($4K). Holdings down 1% to 64,441 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Jul 7, 2026
Jul 2–6, 2026SaleKevin Lee (CEO and Director) sold 7,642 shares between Jul 2 and Jul 6 at about $4.28 ($33K). Holdings down 1% to 603,671 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Jul 7, 2026
Jul 2–6, 2026SaleMichael Skynner (Chief Scientific Officer) sold 2,391 shares between Jul 2 and Jul 6 at about $4.28 ($10K). Holdings down 1% to 157,171 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Jul 7, 2026
Apr 2–6, 2026Planned (10b5-1)Jennifer Scott Perry (President / COO) sold 1,408 shares between Apr 2 and Apr 6 at about $4.94 ($7K), marked as a 10b5-1 plan trade. Holdings down 1% to 92,464 shares.SEC filing
Filed Apr 6, 2026
Apr 2–6, 2026SaleMichael Charles Ferguson Hannay (Chief Prod & Supply Chain Off) sold 1,772 shares between Apr 2 and Apr 6 at about $4.93 ($9K). Holdings down 2% to 96,136 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Apr 6, 2026
Apr 2–6, 2026SaleTravis Alvin Thompson (CFO) sold 901 shares between Apr 2 and Apr 6 at about $4.93 ($4K). Holdings down 1% to 65,364 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Apr 6, 2026
Apr 2–6, 2026SaleKevin Lee (CEO and Director) sold 7,683 shares between Apr 2 and Apr 6 at about $4.94 ($38K). Holdings down 1% to 611,313 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Apr 6, 2026
Apr 2–6, 2026SaleMichael Skynner (Chief Scientific Officer) sold 2,404 shares between Apr 2 and Apr 6 at about $4.94 ($12K). Holdings down 1% to 159,562 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Apr 6, 2026
Jan 2–5, 2026SaleMichael Charles Ferguson Hannay (Chief Prod & Supply Chain Off) sold 5,194 shares between Jan 2 and Jan 5 at about $6.64 ($34K). Holdings down 5% to 97,908 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Jan 6, 2026
Jan 2–5, 2026SaleTravis Alvin Thompson (Chief Accounting Officer) sold 2,432 shares between Jan 2 and Jan 5 at about $6.64 ($16K). Holdings down 4% to 66,265 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Jan 6, 2026
Jan 2–5, 2026Planned (10b5-1)Alethia Young (CFO) sold 7,623 shares between Jan 2 and Jan 5 at about $6.62 ($50K), marked as a 10b5-1 plan trade. Holdings down 8% to 87,081 shares.SEC filing
Filed Jan 6, 2026
Jan 2–5, 2026SaleAlistair Milnes (President / COO) sold 6,660 shares between Jan 2 and Jan 5 at about $6.63 ($44K). Holdings down 5% to 136,717 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Jan 6, 2026
Jan 2–5, 2026SaleKevin Lee (CEO and Director) sold 21,314 shares between Jan 2 and Jan 5 at about $6.62 ($141K). Holdings down 3% to 618,996 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Jan 6, 2026
Jan 2–5, 2026SaleMichael Skynner (Chief Technology Officer) sold 6,311 shares between Jan 2 and Jan 5 at about $6.62 ($42K). Holdings down 4% to 161,966 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Jan 6, 2026

20 routine transactions (such as grants, option exercises or tax withholding) are not listed.

Cluster buys

No cluster buys in the last 12 months.

Red flags

No red flags in the last 12 months.

Key events

No key events in the last 12 months.

8-K filings, last 12 months

No 8-K filings in the last 12 months.

Red flags are objective triggers only: the item or form filed, never an opinion.

Follow BCYC in the Insider Ledger app

A plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.

Get the app